Pd61-11 Initial Experience of Robot-Assisted Radical Prostatectomy Using Hinotori Surgical Robot System

You have accessJournal of UrologyProstate Cancer: Localized: Surgical Therapy IV (PD61)1 May 2024PD61-11 INITIAL EXPERIENCE OF ROBOT-ASSISTED RADICAL PROSTATECTOMY USING HINOTORI SURGICAL ROBOT SYSTEM Mitsugu Kanehira, Makoto Moriwaka, Moe Toyoshima, Masahiro Kurokawa, Kenta Takahashi, Ei Shiomi, Shuhei Ishii, Daiki Ikarashi, Shigekatsu Maekawa, Renpei Kato, Ryo Takata, Jun Sugimura, Takaya Abe, and Wataru Obara Mitsugu KanehiraMitsugu Kanehira , Makoto MoriwakaMakoto Moriwaka , Moe ToyoshimaMoe Toyoshima , Masahiro KurokawaMasahiro Kurokawa , Kenta TakahashiKenta Takahashi , Ei ShiomiEi Shiomi , Shuhei IshiiShuhei Ishii , Daiki IkarashiDaiki Ikarashi , Shigekatsu MaekawaShigekatsu Maekawa , Renpei KatoRenpei Kato , Ryo TakataRyo Takata , Jun SugimuraJun Sugimura , Takaya AbeTakaya Abe , and Wataru ObaraWataru Obara View All Author Informationhttps://doi.org/10.1097/01.JU.0001009352.31737.3d.11AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: With the introduction of robot-assisted surgery, minimally invasive surgery in the field of urology has advanced dramatically. In Japan, only the da Vinci surgical sysytem, a surgical robot approved in 2009, had been available, but the hinotori surgical robot system, a novel domestic robot-assisted surgical system developed, was released in 2020. We started robot-assisted radical prostatectomy using hinotori (hinotori-RARP) in November 2022. Initial outcomes of hinotori-RARP are reported. METHODS: The study cohort consisted of 34 patients who underwent hinotori-RARP from November 2022 to July 2023 in our institute. The surgical procedures were performed by three surgeons. In general, hinotori-RARP was performed by posterior surgical approach, and nerve-sparing was considered on the side where cancer was not detected by biopsy or radiological examination. Lymph node dissection was added to patients based on guidelines. Characteristics, perioperative and postoperative outcomes were retrospectively analyzed.In addition, we compared the outcomes with RARP using da Vinci surgical system (DVSS-RARP) performed by the same surgeons. RESULTS: Median age and iPSA were 69 years and 6.9 ng/mL. There were 5, 19 and 10 patients in low-, Intermediate- and high-risk prostate cancer. Median total operative and cockpit time were 234 and 171 min. Median estimated blood loss was 159.5 mL, and no blood transfusion was needed. There was no conversion to open or laparoscopic surgery. Only one patient had a major complication. Positive surgical margin rates for pT2 and pT3 were 16.7 and 25 %.Compared with DVSS-RARP, there were no differences in outcomes between them. CONCLUSIONS: hinotori-RARP had been safely introduced. The favorable outcomes of hinotori-RARP was comparable to that of DVSS-RARP. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e1284 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Mitsugu Kanehira More articles by this author Makoto Moriwaka More articles by this author Moe Toyoshima More articles by this author Masahiro Kurokawa More articles by this author Kenta Takahashi More articles by this author Ei Shiomi More articles by this author Shuhei Ishii More articles by this author Daiki Ikarashi More articles by this author Shigekatsu Maekawa More articles by this author Renpei Kato More articles by this author Ryo Takata More articles by this author Jun Sugimura More articles by this author Takaya Abe More articles by this author Wataru Obara More articles by this author Expand All Advertisement PDF downloadLoading ...